Healthcare Sector Quant Ratings Update Amid Earnings Season
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Source: seekingalpha
- Sector Underperformance: The Health Care Select Sector SPDR Fund ETF (XLV) has declined 3.17% year-to-date, significantly lagging behind the S&P 500's 9.17% gain, indicating weakness in the healthcare sector amid the current market environment.
- Quant Rating System: Seeking Alpha's quant system rates mid-cap healthcare companies with market caps between $2B and $10B on a scale from 1 to 5, where scores above 3.5 are bullish and below 2.5 are bearish, aiding investors in identifying potential opportunities.
- Top-Rated Stocks: PACS Group (PACS) received a quant rating of 4.80, classified as a Strong Buy, while Indivior Pharmaceuticals (INDV) and Relay Therapeutics (RLAY) follow closely with ratings of 4.77 and 4.73, respectively, showcasing strong post-earnings performance.
- Bottom-Rated Stocks: Doximity (DOCS) and TransMedics Group (TMDX) both received a quant rating of 1.11, categorized as Strong Sell, reflecting their weak positions in the market and suggesting caution for investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PACS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PACS
Wall Street analysts forecast PACS stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 38.000
Low
40.00
Averages
42.60
High
47.00
Current: 38.000
Low
40.00
Averages
42.60
High
47.00
About PACS
PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare Sector Quant Ratings Update Amid Earnings Season
- Sector Underperformance: The Health Care Select Sector SPDR Fund ETF (XLV) has declined 3.17% year-to-date, significantly lagging behind the S&P 500's 9.17% gain, indicating weakness in the healthcare sector amid the current market environment.
- Quant Rating System: Seeking Alpha's quant system rates mid-cap healthcare companies with market caps between $2B and $10B on a scale from 1 to 5, where scores above 3.5 are bullish and below 2.5 are bearish, aiding investors in identifying potential opportunities.
- Top-Rated Stocks: PACS Group (PACS) received a quant rating of 4.80, classified as a Strong Buy, while Indivior Pharmaceuticals (INDV) and Relay Therapeutics (RLAY) follow closely with ratings of 4.77 and 4.73, respectively, showcasing strong post-earnings performance.
- Bottom-Rated Stocks: Doximity (DOCS) and TransMedics Group (TMDX) both received a quant rating of 1.11, categorized as Strong Sell, reflecting their weak positions in the market and suggesting caution for investors.
See More
PACS Group Reports Significant Q1 Earnings Growth
- Significant Revenue Growth: PACS Group's Q1 revenue increased by 11% year-over-year to $1.4 billion, demonstrating strong market demand in the post-acute care sector, particularly driven by the aging U.S. population, which further solidifies its market leadership.
- Enhanced Profitability: PACS' EBITDA soared by 75% to $170 million, reflecting the company's ongoing commitment to operational quality and clinical excellence, thereby boosting investor confidence in its future growth prospects.
- Substantial Expansion Potential: Management anticipates full-year adjusted EBITDA growth of approximately 22% to between $605 million and $625 million by 2026, a significant upward revision from previous estimates, indicating an active pursuit of acquisition opportunities.
- Leading Market Share: With over 320 healthcare operations across 17 states, PACS boasts an overall occupancy rate of 90.8%, significantly exceeding the industry average of 79%, which not only enhances its service capacity but also lays a solid foundation for future expansion.
See More
PACS Group Reports Strong Q1 2026 Earnings with Increased Guidance
- Strong Performance: PACS Group reported Q1 2026 revenue of $1.42 billion and net income of $80.7 million, with adjusted EBITDA at $170.4 million, indicating stable operations and robust market demand that are expected to drive future growth.
- Quality Improvement: As of March 31, 2026, PACS operates 323 facilities across 17 states, with 222 rated 4 or 5 stars under CMS quality measures, up from 207 at the end of 2025, reflecting the company's ongoing commitment to enhancing service quality.
- Share Repurchase Authorization: The PACS Board approved a $250 million share repurchase program aimed at enhancing shareholder value while maintaining approximately $800 million in liquidity to support future investments and acquisition strategies.
- Increased EBITDA Guidance: The company raised its adjusted EBITDA expectations for 2026 to a range of $605 million to $625 million while reaffirming revenue guidance between $5.65 billion and $5.75 billion, demonstrating confidence in future performance and a positive market outlook.
See More
PACS Group Announces Q1 2026 Financial Results Release Plan
- Earnings Release Plan: PACS Group intends to release its Q1 2026 financial results on May 11, 2026, with management hosting a call on May 12 to discuss the results, which is expected to attract investor interest.
- Investor Participation: Investors can join the call via the PACS Group website or by dialing specified numbers, ensuring transparency and accessibility of information, which enhances investor confidence.
- Company Background: Founded in 2013, PACS Group is one of the largest post-acute healthcare companies in the U.S., operating 324 facilities that serve over 31,900 patients daily, highlighting its significant position in the industry.
- Forward-Looking Statements: The company's forward-looking statements emphasize the timeline for financial reporting and potential risks, indicating management's cautious optimism about future performance and reflecting sensitivity to market changes.
See More
PACS Group Acquires Ridgeway Senior Living in Alaska
- Network Expansion: PACS Group has acquired Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state and further solidifying its position in the post-acute care market.
- New Facility Development: The transaction includes the acquisition of adjacent land, with plans to build a 150-bed skilled nursing facility by 2028, aimed at providing a full continuum of care and enhancing community asset value.
- Strategic Growth Vision: PACS CEO Jason Murray stated that this expansion supports the company's locally led and centrally supported model in Alaska, ensuring exceptional service delivery across all levels of acuity to meet market demands.
- National Impact Enhancement: This expansion brings PACS' total community count to 325 across 17 states, providing nearly 36,000 beds, highlighting its revolutionary mission in the national post-acute care landscape.
See More
PACS Group CFO Mark Hancock to Retire in 2026
- Executive Retirement Announcement: PACS Group co-founder and CFO Mark Hancock has announced his retirement effective June 30, 2026, marking a significant shift in the company's leadership that could impact investor confidence in its future financial strategies.
- Board Role Transition: After stepping down as CFO, Hancock will remain on the board as vice chairman, a move aimed at ensuring stability during the transition and leveraging his extensive experience to guide future financial decisions.
- Financial Performance Overview: In Q4 2025, PACS Group reported a GAAP EPS of $1.22 and revenue of $5.29 billion, indicating the company's sustained growth potential in the healthcare sector, although executive changes may have a short-term impact on market sentiment.
- Market Reaction Anticipation: Following the announcement of Hancock's retirement, the market is likely to closely monitor PACS Group's subsequent executive appointments and their implications for the company's strategic direction, particularly in the increasingly competitive healthcare industry.
See More
Healthcare Sector Quant Ratings Update Amid Earnings Season
- Sector Underperformance: The Health Care Select Sector SPDR Fund ETF (XLV) has declined 3.17% year-to-date, significantly lagging behind the S&P 500's 9.17% gain, indicating weakness in the healthcare sector amid the current market environment.
- Quant Rating System: Seeking Alpha's quant system rates mid-cap healthcare companies with market caps between $2B and $10B on a scale from 1 to 5, where scores above 3.5 are bullish and below 2.5 are bearish, aiding investors in identifying potential opportunities.
- Top-Rated Stocks: PACS Group (PACS) received a quant rating of 4.80, classified as a Strong Buy, while Indivior Pharmaceuticals (INDV) and Relay Therapeutics (RLAY) follow closely with ratings of 4.77 and 4.73, respectively, showcasing strong post-earnings performance.
- Bottom-Rated Stocks: Doximity (DOCS) and TransMedics Group (TMDX) both received a quant rating of 1.11, categorized as Strong Sell, reflecting their weak positions in the market and suggesting caution for investors.
See More
PACS Group Reports Significant Q1 Earnings Growth
- Significant Revenue Growth: PACS Group's Q1 revenue increased by 11% year-over-year to $1.4 billion, demonstrating strong market demand in the post-acute care sector, particularly driven by the aging U.S. population, which further solidifies its market leadership.
- Enhanced Profitability: PACS' EBITDA soared by 75% to $170 million, reflecting the company's ongoing commitment to operational quality and clinical excellence, thereby boosting investor confidence in its future growth prospects.
- Substantial Expansion Potential: Management anticipates full-year adjusted EBITDA growth of approximately 22% to between $605 million and $625 million by 2026, a significant upward revision from previous estimates, indicating an active pursuit of acquisition opportunities.
- Leading Market Share: With over 320 healthcare operations across 17 states, PACS boasts an overall occupancy rate of 90.8%, significantly exceeding the industry average of 79%, which not only enhances its service capacity but also lays a solid foundation for future expansion.
See More
PACS Group Reports Strong Q1 2026 Earnings with Increased Guidance
- Strong Performance: PACS Group reported Q1 2026 revenue of $1.42 billion and net income of $80.7 million, with adjusted EBITDA at $170.4 million, indicating stable operations and robust market demand that are expected to drive future growth.
- Quality Improvement: As of March 31, 2026, PACS operates 323 facilities across 17 states, with 222 rated 4 or 5 stars under CMS quality measures, up from 207 at the end of 2025, reflecting the company's ongoing commitment to enhancing service quality.
- Share Repurchase Authorization: The PACS Board approved a $250 million share repurchase program aimed at enhancing shareholder value while maintaining approximately $800 million in liquidity to support future investments and acquisition strategies.
- Increased EBITDA Guidance: The company raised its adjusted EBITDA expectations for 2026 to a range of $605 million to $625 million while reaffirming revenue guidance between $5.65 billion and $5.75 billion, demonstrating confidence in future performance and a positive market outlook.
See More
PACS Group Announces Q1 2026 Financial Results Release Plan
- Earnings Release Plan: PACS Group intends to release its Q1 2026 financial results on May 11, 2026, with management hosting a call on May 12 to discuss the results, which is expected to attract investor interest.
- Investor Participation: Investors can join the call via the PACS Group website or by dialing specified numbers, ensuring transparency and accessibility of information, which enhances investor confidence.
- Company Background: Founded in 2013, PACS Group is one of the largest post-acute healthcare companies in the U.S., operating 324 facilities that serve over 31,900 patients daily, highlighting its significant position in the industry.
- Forward-Looking Statements: The company's forward-looking statements emphasize the timeline for financial reporting and potential risks, indicating management's cautious optimism about future performance and reflecting sensitivity to market changes.
See More
PACS Group Acquires Ridgeway Senior Living in Alaska
- Network Expansion: PACS Group has acquired Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state and further solidifying its position in the post-acute care market.
- New Facility Development: The transaction includes the acquisition of adjacent land, with plans to build a 150-bed skilled nursing facility by 2028, aimed at providing a full continuum of care and enhancing community asset value.
- Strategic Growth Vision: PACS CEO Jason Murray stated that this expansion supports the company's locally led and centrally supported model in Alaska, ensuring exceptional service delivery across all levels of acuity to meet market demands.
- National Impact Enhancement: This expansion brings PACS' total community count to 325 across 17 states, providing nearly 36,000 beds, highlighting its revolutionary mission in the national post-acute care landscape.
See More
PACS Group CFO Mark Hancock to Retire in 2026
- Executive Retirement Announcement: PACS Group co-founder and CFO Mark Hancock has announced his retirement effective June 30, 2026, marking a significant shift in the company's leadership that could impact investor confidence in its future financial strategies.
- Board Role Transition: After stepping down as CFO, Hancock will remain on the board as vice chairman, a move aimed at ensuring stability during the transition and leveraging his extensive experience to guide future financial decisions.
- Financial Performance Overview: In Q4 2025, PACS Group reported a GAAP EPS of $1.22 and revenue of $5.29 billion, indicating the company's sustained growth potential in the healthcare sector, although executive changes may have a short-term impact on market sentiment.
- Market Reaction Anticipation: Following the announcement of Hancock's retirement, the market is likely to closely monitor PACS Group's subsequent executive appointments and their implications for the company's strategic direction, particularly in the increasingly competitive healthcare industry.
See More
